NCT07291674Not yet recruiting
Predictors and Outcome of Rupture HCC in AU Hospitals
Predictors and Outcome of Rupture Hepatocellular Carcinoma in Assuit Unversity Hospitals
Source: ClinicalTrials.gov · Last updated 18 Dec 2025
Brief summary (registry, in English)
The aime of the study is To identify the Prevalence of rupture of HCC among patients diagnosed with HCC at Assiut University Hospitals in the last five years. ,detect the Risk factors and predictors of rupture HCC. and identify the survival rate in 1 year post rupture HCC patients.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 28 Sept 2025
- Start date
- Jan 2026
- Primary completion date
- Aug 2026
- Lead sponsor
- Assiut University
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT07291674
What you commit to
- Study type: Observational
- Planned participants: 100
- From Jan 2026 to the primary completion date, Aug 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- \* Traumatic liver rupture
- Non-HCC liver malignancies
- Incomplete medical records or missing imaging data
Who the study is looking for
- \*Age ≥18 years
- Diagnosed with HCC (radiologically or histopathologically)
- Evidence of spontaneous rupture confirmed by imaging or surgical exploration
- Admitted to the hospital during the study period
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.